Walter Stockinger
Managing Partner @ Hadean Ventures
Ebenfurth, Austria
Walter Stockinger is a Series A investor at Hadean Ventures in Ebenfurth focused on Biotechnology and Medical. Walter Stockinger is based out of Ebenfurth, Niederösterreich, and is the managing partner of Hadean Ventures. Walter previously worked at Inventages Venture Capital as a board member and board observer. Walter Stockinger attended the University of Vienna.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries Walter Stockinger invests in
Stages Walter Stockinger invests in
Countries Walter Stockinger invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 5 (83%)
- Medical 1 (17%)
- Genetics 1 (17%)
- Health Care 1 (17%)
- Pharmaceutical 1 (17%)
Stage
- Series A 3 (50%)
- Series B 1 (17%)
- Series C 1 (17%)
- Series D 1 (17%)
Country
- Austria 3 (50%)
- France 1 (17%)
- Sweden 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $44.3M / Series C / Oct 15, 2025 | ||
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $19.7M / Series A / Jan 31, 2022 | ||
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $20.2M / Series A / Jan 31, 2022 | ||
| Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $41.3M / Series B / Mar 24, 2021 | ||
| Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing andacquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies. | $44.1M / Series D / Sep 18, 2019 | ||
| SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity. | $4.2M / Series A / Jun 11, 2019 |
Co-Investors
About Hadean Ventures
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Hadean Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Florian Eckhardt
Senior Investment Director
|
|||
Ingrid Akay
Founder and Managing Partner
|
|||
Ingrid Beyer
Head of Investor Relations
|
|||
Roger Franklin
Partner
|
|||
|
Walter Stockinger
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Walter Stockinger invest in?
Walter Stockinger invests primarily in Biotechnology, Medical and Genetics startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Walter Stockinger?
Public channels for Walter Stockinger include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Walter Stockinger last invest?
The most recent investment recorded for Walter Stockinger closed in Oct 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
